Trials / Unknown
UnknownNCT00196157
Line Versus Spot Ablation in Persistent Atrial Fibrillation
Linear Anatomically Versus Focal Electrophysiologically Guided Substrate Ablation in Patients With Persistent Atrial Fibrillation
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 116 (estimated)
- Sponsor
- Deutsches Herzzentrum Muenchen · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
In this randomized study dealing with the ablative treatment of persistent atrial fibrillation, two ablation strategies are compared: a more anatomically guided linear ablation scheme versus an electrophysiological guided focal ablation strategy aiming at the electrical isolating of the pulmonary veins and ablating areas of fragmented intracardiac electrograms thought to maintain atrial fibrillation.
Detailed description
This randomized study deals with two different ablative treatment strategies for persistent atrial fibrillation: a more anatomically guided linear ablation scheme with encircling of the ipsilateral pulmonary veins (PV), a left atrial roof line and an anterior line bridging the anterior mitral anulus to the ostium of the left superior PV versus an electrophysiological guided focal ablation strategy aiming at isolating, electrically, the PV and ablating areas of fragmented intracardiac electrograms thought to maintain atrial fibrillation. Both ablation approaches contain isolation of the most common source of triggering foci, i.e., the pulmonary veins and additional modification of the substrate maintaining atrial fibrillation. The study endpoint is a combined efficacy/safety analysis. Extensive follow-up with three-monthly 7 days holter ECG is provided.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | linear anatomically oriented ablations | linear lesions to ablate persistent atrial fibrillation |
| PROCEDURE | focal electrophysiological oriented ablations | focal electrophysiologically guided ablations to treat persistent atrial fibrillation |
Timeline
- Start date
- 2004-08-01
- Primary completion
- 2008-05-01
- Completion
- 2008-11-01
- First posted
- 2005-09-20
- Last updated
- 2009-05-29
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00196157. Inclusion in this directory is not an endorsement.